2015-2025 Global Opioid-induced Constipation Market Research by Type, End-Use and Region
SUMMARY
The global Opioid-induced Constipation market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
The global Opioid-induced Constipation market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- AstraZeneca
- Takeda Pharmaceutical
- Valeant Pharmaceuticals International
- Abbott
- Bayer
- Boehringer Ingelheim
- C.B. Fleet
- Cosmo Pharmaceuticals
- Daewoong
- Daiichi Sankyo
- GlaxoSmithKline
- Ironwood Pharmaceuticals
- Johnson & Johnson
- Merck
- Mundipharma
- Nektar Therapeutics
- Pfizer
- Progenics Pharmaceuticals
- Shionogi
- SLA Pharma
- Sucampo
- Synergy Pharmaceuticals
- Theravance
- Solid
- Liquid
- Drugstore
- Hospital
- Others
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Europe Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Europe Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Europe Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure America Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table America Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure America Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Asia Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Asia Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Asia Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Oceania Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Africa Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Africa Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Africa Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Opioid-induced Constipation Production Forecast
Figure Global Opioid-induced Constipation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Opioid-induced Constipation Forecast by Type
Table Global Opioid-induced Constipation Revenue by Type, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2025 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2025 (Volume)
8.3 Global Opioid-induced Constipation Forecast by End-Use (2020E-2025F)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Opioid-induced Constipation Forecast by Region (2020E-2025F)
Table Global Opioid-induced Constipation Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by Region in 2025 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 AstraZeneca
9.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.1.2 AstraZeneca Products & Services
9.1.3 AstraZeneca Company Dynamics & News
9.1.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Takeda Pharmaceutical
9.2.1 Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Overview List
9.2.2 Takeda Pharmaceutical Products & Services
9.2.3 Takeda Pharmaceutical Company Dynamics & News
9.2.4 Takeda Pharmaceutical Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Valeant Pharmaceuticals International
9.3.1 Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Overview List
9.3.2 Valeant Pharmaceuticals International Products & Services
9.3.3 Valeant Pharmaceuticals International Company Dynamics & News
9.3.4 Valeant Pharmaceuticals International Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Abbott
9.4.1 Abbott Profile
Table Abbott Overview List
9.4.2 Abbott Products & Services
9.4.3 Abbott Company Dynamics & News
9.4.4 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Bayer
9.5.1 Bayer Profile
Table Bayer Overview List
9.5.2 Bayer Products & Services
9.5.3 Bayer Company Dynamics & News
9.5.4 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.6.2 Boehringer Ingelheim Products & Services
9.6.3 Boehringer Ingelheim Company Dynamics & News
9.6.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 C.B. Fleet
9.7.1 C.B. Fleet Profile
Table C.B. Fleet Overview List
9.7.2 C.B. Fleet Products & Services
9.7.3 C.B. Fleet Company Dynamics & News
9.7.4 C.B. Fleet Business Operation Conditions
Table Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Cosmo Pharmaceuticals
9.8.1 Cosmo Pharmaceuticals Profile
Table Cosmo Pharmaceuticals Overview List
9.8.2 Cosmo Pharmaceuticals Products & Services
9.8.3 Cosmo Pharmaceuticals Company Dynamics & News
9.8.4 Cosmo Pharmaceuticals Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Daewoong
9.9.1 Daewoong Profile
Table Daewoong Overview List
9.9.2 Daewoong Products & Services
9.9.3 Daewoong Company Dynamics & News
9.9.4 Daewoong Business Operation Conditions
Table Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
9.10.2 Daiichi Sankyo Products & Services
9.10.3 Daiichi Sankyo Company Dynamics & News
9.10.4 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.11.2 GlaxoSmithKline Products & Services
9.11.3 GlaxoSmithKline Company Dynamics & News
9.11.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Ironwood Pharmaceuticals
9.12.1 Ironwood Pharmaceuticals Profile
Table Ironwood Pharmaceuticals Overview List
9.12.2 Ironwood Pharmaceuticals Products & Services
9.12.3 Ironwood Pharmaceuticals Company Dynamics & News
9.12.4 Ironwood Pharmaceuticals Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.13 Johnson & Johnson
9.13.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.13.2 Johnson & Johnson Products & Services
9.13.3 Johnson & Johnson Company Dynamics & News
9.13.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Merck
9.14.1 Merck Profile
Table Merck Overview List
9.14.2 Merck Products & Services
9.14.3 Merck Company Dynamics & News
9.14.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.15 Mundipharma
9.15.1 Mundipharma Profile
Table Mundipharma Overview List
9.15.2 Mundipharma Products & Services
9.15.3 Mundipharma Company Dynamics & News
9.15.4 Mundipharma Business Operation Conditions
Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)
9.16 Nektar Therapeutics
9.16.1 Nektar Therapeutics Profile
Table Nektar Therapeutics Overview List
9.16.2 Nektar Therapeutics Products & Services
9.16.3 Nektar Therapeutics Company Dynamics & News
9.16.4 Nektar Therapeutics Business Operation Conditions
Table Business Operation of Nektar Therapeutics (Sales Revenue, Cost, Gross Margin)
9.17 Pfizer
9.17.1 Pfizer Profile
Table Pfizer Overview List
9.17.2 Pfizer Products & Services
9.17.3 Pfizer Company Dynamics & News
9.17.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
9.18 Progenics Pharmaceuticals
9.18.1 Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Overview List
9.18.2 Progenics Pharmaceuticals Products & Services
9.18.3 Progenics Pharmaceuticals Company Dynamics & News
9.18.4 Progenics Pharmaceuticals Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.19 Shionogi
9.19.1 Shionogi Profile
Table Shionogi Overview List
9.19.2 Shionogi Products & Services
9.19.3 Shionogi Company Dynamics & News
9.19.4 Shionogi Business Operation Conditions
Table Business Operation of Shionogi (Sales Revenue, Cost, Gross Margin)
9.20 SLA Pharma
9.20.1 SLA Pharma Profile
Table SLA Pharma Overview List
9.20.2 SLA Pharma Products & Services
9.20.3 SLA Pharma Company Dynamics & News
9.20.4 SLA Pharma Business Operation Conditions
Table Business Operation of SLA Pharma (Sales Revenue, Cost, Gross Margin)
9.21 Sucampo
9.21.1 Sucampo Profile
Table Sucampo Overview List
9.21.2 Sucampo Products & Services
9.21.3 Sucampo Company Dynamics & News
9.21.4 Sucampo Business Operation Conditions
Table Business Operation of Sucampo (Sales Revenue, Cost, Gross Margin)
9.22 Synergy Pharmaceuticals
9.22.1 Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Overview List
9.22.2 Synergy Pharmaceuticals Products & Services
9.22.4 Synergy Pharmaceuticals Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.23 Theravance
9.23.1 Theravance Profile
Table Theravance Overview List
9.23.2 Theravance Products & Services
9.23.3 Theravance Company Dynamics & News
9.23.4 Theravance Business Operation Conditions
Table Business Operation of Theravance (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Opioid-induced Constipation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid-induced Constipation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid-induced Constipation Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure America Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Asia Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Oceania Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Africa Opioid-induced Constipation Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON OPIOID-INDUCED CONSTIPATION INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 OPIOID-INDUCED CONSTIPATION INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Europe Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Europe Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Europe Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure America Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table America Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure America Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Asia Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Asia Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Asia Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Oceania Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Figure Africa Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Table Africa Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Figure Africa Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Opioid-induced Constipation Production Forecast
Figure Global Opioid-induced Constipation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Opioid-induced Constipation Forecast by Type
Table Global Opioid-induced Constipation Revenue by Type, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2025 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2025 (Volume)
8.3 Global Opioid-induced Constipation Forecast by End-Use (2020E-2025F)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Opioid-induced Constipation Forecast by Region (2020E-2025F)
Table Global Opioid-induced Constipation Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by Region in 2025 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 AstraZeneca
9.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.1.2 AstraZeneca Products & Services
9.1.3 AstraZeneca Company Dynamics & News
9.1.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Takeda Pharmaceutical
9.2.1 Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Overview List
9.2.2 Takeda Pharmaceutical Products & Services
9.2.3 Takeda Pharmaceutical Company Dynamics & News
9.2.4 Takeda Pharmaceutical Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Valeant Pharmaceuticals International
9.3.1 Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Overview List
9.3.2 Valeant Pharmaceuticals International Products & Services
9.3.3 Valeant Pharmaceuticals International Company Dynamics & News
9.3.4 Valeant Pharmaceuticals International Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Abbott
9.4.1 Abbott Profile
Table Abbott Overview List
9.4.2 Abbott Products & Services
9.4.3 Abbott Company Dynamics & News
9.4.4 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Bayer
9.5.1 Bayer Profile
Table Bayer Overview List
9.5.2 Bayer Products & Services
9.5.3 Bayer Company Dynamics & News
9.5.4 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.6.2 Boehringer Ingelheim Products & Services
9.6.3 Boehringer Ingelheim Company Dynamics & News
9.6.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 C.B. Fleet
9.7.1 C.B. Fleet Profile
Table C.B. Fleet Overview List
9.7.2 C.B. Fleet Products & Services
9.7.3 C.B. Fleet Company Dynamics & News
9.7.4 C.B. Fleet Business Operation Conditions
Table Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Cosmo Pharmaceuticals
9.8.1 Cosmo Pharmaceuticals Profile
Table Cosmo Pharmaceuticals Overview List
9.8.2 Cosmo Pharmaceuticals Products & Services
9.8.3 Cosmo Pharmaceuticals Company Dynamics & News
9.8.4 Cosmo Pharmaceuticals Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Daewoong
9.9.1 Daewoong Profile
Table Daewoong Overview List
9.9.2 Daewoong Products & Services
9.9.3 Daewoong Company Dynamics & News
9.9.4 Daewoong Business Operation Conditions
Table Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
9.10.2 Daiichi Sankyo Products & Services
9.10.3 Daiichi Sankyo Company Dynamics & News
9.10.4 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.11.2 GlaxoSmithKline Products & Services
9.11.3 GlaxoSmithKline Company Dynamics & News
9.11.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Ironwood Pharmaceuticals
9.12.1 Ironwood Pharmaceuticals Profile
Table Ironwood Pharmaceuticals Overview List
9.12.2 Ironwood Pharmaceuticals Products & Services
9.12.3 Ironwood Pharmaceuticals Company Dynamics & News
9.12.4 Ironwood Pharmaceuticals Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.13 Johnson & Johnson
9.13.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.13.2 Johnson & Johnson Products & Services
9.13.3 Johnson & Johnson Company Dynamics & News
9.13.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Merck
9.14.1 Merck Profile
Table Merck Overview List
9.14.2 Merck Products & Services
9.14.3 Merck Company Dynamics & News
9.14.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.15 Mundipharma
9.15.1 Mundipharma Profile
Table Mundipharma Overview List
9.15.2 Mundipharma Products & Services
9.15.3 Mundipharma Company Dynamics & News
9.15.4 Mundipharma Business Operation Conditions
Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)
9.16 Nektar Therapeutics
9.16.1 Nektar Therapeutics Profile
Table Nektar Therapeutics Overview List
9.16.2 Nektar Therapeutics Products & Services
9.16.3 Nektar Therapeutics Company Dynamics & News
9.16.4 Nektar Therapeutics Business Operation Conditions
Table Business Operation of Nektar Therapeutics (Sales Revenue, Cost, Gross Margin)
9.17 Pfizer
9.17.1 Pfizer Profile
Table Pfizer Overview List
9.17.2 Pfizer Products & Services
9.17.3 Pfizer Company Dynamics & News
9.17.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
9.18 Progenics Pharmaceuticals
9.18.1 Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Overview List
9.18.2 Progenics Pharmaceuticals Products & Services
9.18.3 Progenics Pharmaceuticals Company Dynamics & News
9.18.4 Progenics Pharmaceuticals Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.19 Shionogi
9.19.1 Shionogi Profile
Table Shionogi Overview List
9.19.2 Shionogi Products & Services
9.19.3 Shionogi Company Dynamics & News
9.19.4 Shionogi Business Operation Conditions
Table Business Operation of Shionogi (Sales Revenue, Cost, Gross Margin)
9.20 SLA Pharma
9.20.1 SLA Pharma Profile
Table SLA Pharma Overview List
9.20.2 SLA Pharma Products & Services
9.20.3 SLA Pharma Company Dynamics & News
9.20.4 SLA Pharma Business Operation Conditions
Table Business Operation of SLA Pharma (Sales Revenue, Cost, Gross Margin)
9.21 Sucampo
9.21.1 Sucampo Profile
Table Sucampo Overview List
9.21.2 Sucampo Products & Services
9.21.3 Sucampo Company Dynamics & News
9.21.4 Sucampo Business Operation Conditions
Table Business Operation of Sucampo (Sales Revenue, Cost, Gross Margin)
9.22 Synergy Pharmaceuticals
9.22.1 Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Overview List
9.22.2 Synergy Pharmaceuticals Products & Services
9.22.4 Synergy Pharmaceuticals Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.23 Theravance
9.23.1 Theravance Profile
Table Theravance Overview List
9.23.2 Theravance Products & Services
9.23.3 Theravance Company Dynamics & News
9.23.4 Theravance Business Operation Conditions
Table Business Operation of Theravance (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Opioid-induced Constipation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid-induced Constipation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid-induced Constipation Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure America Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Asia Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Oceania Opioid-induced Constipation Market Concentration Ratio in 2020E
Figure Africa Opioid-induced Constipation Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON OPIOID-INDUCED CONSTIPATION INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 OPIOID-INDUCED CONSTIPATION INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table America Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table America Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Revenue by Type, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2020E-2025F (Volume)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Opioid-induced Constipation Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2020E-2025F (Volume)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Overview List
Table Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Overview List
Table Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ironwood Pharmaceuticals Overview List
Table Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Mundipharma Overview List
Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Business Operation of Nektar Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Progenics Pharmaceuticals Overview List
Table Business Operation of Progenics Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Shionogi Overview List
Table Business Operation of Shionogi (Sales Revenue, Cost, Gross Margin)
Table SLA Pharma Overview List
Table Business Operation of SLA Pharma (Sales Revenue, Cost, Gross Margin)
Table Sucampo Overview List
Table Business Operation of Sucampo (Sales Revenue, Cost, Gross Margin)
Table Synergy Pharmaceuticals Overview List
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Theravance Overview List
Table Business Operation of Theravance (Sales Revenue, Cost, Gross Margin)
Table Global Opioid-induced Constipation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid-induced Constipation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid-induced Constipation Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table America Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table America Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Opioid-induced Constipation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Opioid-induced Constipation Revenue by Type, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Production Volume by Type, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Opioid-induced Constipation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid-induced Constipation Consumption Volume by Region, 2015-2020 (Volume)
Table Global Opioid-induced Constipation Revenue by Type, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Production Volume by Type, 2020E-2025F (Volume)
Table Global Opioid-induced Constipation Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Opioid-induced Constipation Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Opioid-induced Constipation Consumption Volume by Region, 2020E-2025F (Volume)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Overview List
Table Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Overview List
Table Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ironwood Pharmaceuticals Overview List
Table Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Mundipharma Overview List
Table Business Operation of Mundipharma (Sales Revenue, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Business Operation of Nektar Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Progenics Pharmaceuticals Overview List
Table Business Operation of Progenics Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Shionogi Overview List
Table Business Operation of Shionogi (Sales Revenue, Cost, Gross Margin)
Table SLA Pharma Overview List
Table Business Operation of SLA Pharma (Sales Revenue, Cost, Gross Margin)
Table Sucampo Overview List
Table Business Operation of Sucampo (Sales Revenue, Cost, Gross Margin)
Table Synergy Pharmaceuticals Overview List
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Theravance Overview List
Table Business Operation of Theravance (Sales Revenue, Cost, Gross Margin)
Table Global Opioid-induced Constipation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid-induced Constipation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid-induced Constipation Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Europe Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Europe Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure America Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure America Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Asia Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Asia Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Oceania Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Oceania Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Africa Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Africa Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Opioid-induced Constipation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2025 (Million USD)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2025 (Volume)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by Region in 2025 (Million USD)
Figure Global Opioid-induced Constipation Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Opioid-induced Constipation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid-induced Constipation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Europe Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Europe Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure America Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure America Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Asia Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Asia Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Oceania Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Oceania Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Opioid-induced Constipation Revenue Share by Type in 2020 (Million USD)
Figure Africa Opioid-induced Constipation Production Volume Share by Type in 2020 (Volume)
Figure Africa Opioid-induced Constipation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Opioid-induced Constipation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Opioid-induced Constipation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid-induced Constipation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Opioid-induced Constipation Revenue Share by Type in 2025 (Million USD)
Figure Global Opioid-induced Constipation Production Volume Share by Type in 2025 (Volume)
Figure Global Opioid-induced Constipation Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Opioid-induced Constipation Consumption Value Share by Region in 2025 (Million USD)
Figure Global Opioid-induced Constipation Consumption Volume Share by Region in 2025 (Volume)
